Management & Directors
Christopher Knauf: CEO, Interim CFO, Interim Secretary
Christopher Knauf, age 44, is the CEO of True Nature Holding, Inc. From 2014 to present, Mr. Knauf served as a consultant for small to mid-size emerging growth companies, both public and private. From 2012 to 2014, he served as CEO/CFO of Built NY, Inc, a consumer products company based in New York, NY. Prior to that, from 2004 to 2012, Mr. Knauf was Head of Finance and Operations for the Consumer Products division of A+E Networks, Inc, a provider of television content worldwide. From 2002 to 2004, He was the CFO of Intermix, Inc, a New York, NY based apparel retailer. His education includes an MBA, Finance concentration, 1999, Fordham University, New York, NY. BS, Finance, 1995, Fairfield University, Fairfield, CT.
Louis Deluca: Chief Operations Officer
Louis Deluca, age 58, is the COO of True Nature Holding, Inc. Mr. Deluca served as VP of Operations for Mondetta US, Inc. – an online apparel designer and retailer – from 2015 to 2016. From 2012 to 2015, he served as the COO of The Ivory Company, a multichannel home décor retailer based in Atlanta, GA. From 2007 to present, Mr. Deluca was the Founder and CEO of Marietta Sign Company, a manufacturer and designer of customer signage based in Atlanta, GA. From 1981 to 2007, he served as Director of Inventory Planning and Sourcing for The Home Depot. He received a Technical Drafting Certificate from Gwinnett Technical College in 1977 and studied Business Management at the University of Phoenix.
Dr. Jordan Balencic, D.O.: Chairman of the Board of Directors
Dr. Jordan Balencic, D.O. age 30, is a physician entrepreneur and founder of businesses in the telemedicine, marketing and web services, and healthcare product development areas. Dr. Balencic completed his Internal Medicine Residency training at Pennsylvania State University, obtained his Medical Doctoral degree at Lake Erie College of Osteopathic Medicine, and earned his B.S. in Biology from Gannon University. He belongs to numerous professional organizations, and serves the Veterans Administration as a primary care physician.
James Czirr: Director
Mr. James Czirr, age 62, is most recently involved with Galectin Therapeutics, Inc. (NASDAQ:GALT). He served as Chairman of the Board for Galectin from February 2009, and Executive Chairman from February 2010 until January 2016. He now sits on the Board as the representative for their Series B Preferred holders. He is a co-founder of 10X Fund, L.P. and is a managing member of 10X Capital Management LLC, the general partner of 10X Fund, L.P. Mr. Czirr was a co-founder of Galectin Therapeutics in July 2000. Mr. Czirr was instrumental in the early stage development of Safe Science Inc., a developer of anti-cancer drugs; served from 2005 to 2008 as CEO of Minerva Biotechnologies Corporation, a developer of nano particle bio chips to determine the cause of solid tumors; and was a consultant to Metalline Mining Company Inc., now known as Silver Bull Resources, Inc., (AMEX: SVBL), a mineral exploration company seeking to become a low-cost producer of zinc. Mr. Czirr received a B.B.A. degree from the University of Michigan.
ADVISORY BOARD MEMBERS:
On September 28, 2016, the Board agreed to create a non-executive, non-governance Advisory Board and appoint individuals who have technical skills in the healthcare and pharmacy area, and who can advise the Company. These are non-operational roles, and are not subject to the requirements of Section 16 of the Securities Act. Their compensation shall be the issuance of 100,000 shares of restricted common stock for the next 12 months of service.
- Dr. James G. McMurray, M.D., age 75, is an early investor in the True Nature Holding, Inc. and a 40+ year practicing Urologist located in Huntsville, AL, where he is Medical Director and Principal Investigator of Urology for the Medical Affiliated Research Center (http://www.marc-research.com), an independent clinical research entity funded by pharmaceutical companies. He is an AUA Board Certified Urologist who has led numerous trials associated with urology.
- Phillip Giordano, age 57, is the owner of a compounding pharmacy in Boca Raton, Florida which specializes in both veterinary medicine as well as specialized human medications. He is a licensed pharmacist, and has advised the Company since the formation of Newco4pharmacy, LLC, which was acquired by the Company in 2015. Previously as Director of Pharmacy Services in Pompano Beach, Florida, he was responsible for sales and distribution of all internet related prescription sales in 16 states, and internationally.
- C. Leo Smith, age 48, is the former Chairman of the Board of Directors and former Chief Executive and Chief Financial Officer of several private and U.S. public companies He is mostly focused on Mergers and Acquisitions and consolidating small private companies into larger public companies that will bring value and strong dividends to its investors, and shareholder base. Mr. Smith is very active both in the private and public sector and continuously is looking to build and grow small private entities into larger Multinational companies. His experience is diverse in many areas of business, for example: manufacturing, pharmaceutical distribution, service industry, international consulting, staffing, and most recently expanding into direct retail.